Latest Blog Posts Tagged "Clinician"
December 08, 2016
Voyager Therapeutics announced results from a trial, supported in early stages by MJFF, to help the brain convert levodopa to dopamine and better control motor symptoms.
December 01, 2016
Two recently published studies, one MJFF-funded, point to mutations in the GBA gene that may predispose some to cognitive problems with Parkinson's disease.
October 05, 2016
The Michael J. Fox Foundation has piloted efforts to educate busy practicing clinicians about ongoing research and ways in which they can partner with their patients to get involved.
September 21, 2016
A new formulation of amantadine to better treat levodopa-induced dyskinesia is entering the home stretch.
September 07, 2016
Austrian biotech AFFiRiS reports a boost dose of its vaccine against key protein alpha-synuclein is safe and elicits antibodies. MJFF funded the trial.
July 12, 2016
Today MJFF, the Van Andel Research Institute and the Cure Parkinson's Trust announced plans to collaborate to assess the clinical use and development of cancer drug nilotinib.
May 31, 2016
Nuplazid, a drug indicated for the treatment of Parkinson's disease psychosis, is now available for prescription.
May 25, 2016
Today the Foundation announced funding for two projects leveraging the promise of engineered stem cells to speed new therapies and deeper understanding of Parkinson's disease.
May 09, 2016
MJFF is addressing the growing need for doctors who are experts in the treatment of PD by engaging with students and learning from professionals practicing in the field of movement disorders.
April 29, 2016
The Food and Drug Administration has approved Nuplazid to treat Parkinson's psychosis.